Company Filing History:
1 out of 1 
1 out of 2 Years Active: 2012-2013
Title: Discovering the Innovations of Jefferey Stephen Boyle
Introduction
Jefferey Stephen Boyle, an inventive mind located in Heidelberg, Australia, has significantly contributed to the field of immunology with his innovative approach to vaccine development. With a portfolio boasting two patents, Boyle exemplifies the spirit of research and discovery that drives medical advancements.
Latest Patents
Jefferey's most recent innovations include the "Relay Vaccine" and "Antigen Targeting." The Relay Vaccine provides a method and composition for eliciting an immune response in animals through a unique method of administering a carrier and an antigen that is bound to a targeting moiety. This targeting moiety is designed to bind to specific receptors that appear on lymphocytes, which migrate to mucosal lymphoid tissues.
His second patent, Antigen Targeting, outlines a method that similarly elicits an immune response in animals. This method employs a composition comprising a carrier and an antigen bound to a targeting moiety that can attach itself to receptors present in the circulatory vessels of Gut Associated Lymphoid Tissue. Notably, the targeting moiety is preferred to bind with the Mucosal Addressin Cellular Adhesion Molecule-1 (MAdCAM-1), emphasizing the targeted nature of his innovations.
Career Highlights
Throughout his career, Jefferey has been associated with renowned institutions such as the Queensland Institute of Medical Research, where he contributed to pioneering research aimed at improving health outcomes through his work in immunology. His role at this institution has enabled him to push the envelope of what's possible in vaccine development.
Collaborations
In his journey into breakthroughs in immunology, Jefferey has collaborated with esteemed colleagues including Brent Steven McKenzie and Andrew Mark Lew. These partnerships have facilitated a collaborative environment where innovative ideas can thrive, ultimately leading to substantial advancements in the field.
Conclusion
Jefferey Stephen Boyle's contributions to vaccine innovation illustrate the essential role of inventive scientists in shaping the future of medical science. With his impressive patents and collaborative endeavors, Boyle continues to inspire the next generation of innovators in immunology and beyond. As the field progresses, his work will likely remain foundational in the development of targeted vaccines and therapies.